at Benzinga.com (Dec 30, 2014)
Baird's research team still looks for more signs of a revenue uptick before issuing an upgrade...
Baird's research team still looks for more signs of a revenue uptick before issuing an upgrade on Dendreon (DNDN +2.7%), but it sees management starting a credible turnaround path and suggests some exposure given the negative sentiment and low valuation. Near-term Provenge problems seem fixable, the firm says, and cost-efficiency measures should lower cost of goods sold.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Nov 18, 2014)
at Zacks.com (Nov 11, 2014)
at CNBC.com (Nov 10, 2014)
at Zacks.com (Nov 10, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs